Moreover, we performed GAP-43 immunohistochemistry using the age-matched healthy control or the brain sections of a patient with AD and observed a reduction of GAP-43, which is consistent with the Allen Brain Atlas database (Figure 1D). Here, GAP43 is linked to Alzheimer disease.